Literature DB >> 10496662

Substituted amylose as a matrix for sustained drug release.

C Chebli1, I Moussa, S Buczkowski, L Cartilier.   

Abstract

PURPOSE: Amylose derivatives form an important group of polymers, and many of them can be used as drug sustained-release systems.
METHODS: Substituted amylose can be prepared in a 1-step reaction with substituent(s) in a basic medium. The substituents can be represented as (A-R), where (A) serves an epoxy, halide or suitable organic or inorganic function reacting with hydroxyl groups located on the amylose chain, and (R) is an organic radical.
RESULTS: The present work shows the synthesis of different polymers and the effect of different (A) and/or (R) and their different degrees of substitution (n) on the sustained drug release from matrix tablets prepared by direct compression.
CONCLUSIONS: SA polymers are interesting excipients for the preparation of controlled drug release tablets.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10496662     DOI: 10.1023/a:1018963428219

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  4 in total

Review 1.  The structure and interactions of starch with food constituents.

Authors:  C G Biliaderis
Journal:  Can J Physiol Pharmacol       Date:  1991-01       Impact factor: 2.273

2.  Chemically-modified polysaccharides for enzymatically-controlled oral drug delivery.

Authors:  J Kost; S Shefer
Journal:  Biomaterials       Date:  1990-11       Impact factor: 12.479

3.  Preparation and evaluation of sustained release tablets prepared with alpha-starch.

Authors:  M Nakano; N Nakazono; N Inotsume
Journal:  Chem Pharm Bull (Tokyo)       Date:  1987-10       Impact factor: 1.645

4.  Analysis of Fickian and non-Fickian drug release from polymers.

Authors:  N A Peppas
Journal:  Pharm Acta Helv       Date:  1985
  4 in total
  1 in total

1.  High-amylose sodium carboxymethyl starch matrices: development and characterization of tramadol hydrochloride sustained-release tablets for oral administration.

Authors:  Teresa Nabais; Grégoire Leclair
Journal:  ISRN Pharm       Date:  2014-04-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.